SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund (USO) is trending as renewed military strikes in the Middle East and Iranian missile activity shatter previous diplomatic de-escalation narratives, reigniting fears of supply disruptions. The community is actively debating whether these geopolitical escalations signal a sustained move toward higher oil prices or if the asset remains subject to manipulative trading and temporary 'peace' headlines.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently trading in a tight consolidation range as investors prepare for upcoming earnings that will serve as a crucial test for its AI growth narrative. The community is actively debating the stock's long-term valuation versus the company's operational scaling, with intense focus on whether enterprise adoption and revenue growth can sustain a rebound from recent market pressure.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Investors are closely tracking TG Therapeutics as market speculation intensifies around potential acquisition interest and the anticipation of upcoming quarterly earnings results. The community remains focused on the company's Briumvi product growth, potential pipeline expansion, and the expectation of long-term value despite ongoing sector volatility.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol Myers Squibb is trending as investors focus on its pipeline pivot and oncology strategy, with recent bullish momentum fueled by a collaboration with Janux Therapeutics and positive Phase 3 results for mezigdomide. Community sentiment remains fixated on the company's ability to navigate the upcoming patent cliff through strategic acquisitions and pipeline expansion, while traders monitor key breakout levels following recent earnings and analyst upgrades.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is currently experiencing high volatility driven by a mix of shifting geopolitical tensions in the Middle East, fluctuations in energy demand, and ongoing developments regarding the pending acquisition of Valaris. While the community remains divided over the impact of these factors and the stock's long-term valuation, investors are closely monitoring potential contract backlog growth and debt reduction progress as key catalysts for future performance.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is currently trending as investors debate dividend payout projections and weigh the fund's covered-call strategy against other income-focused options. The community is actively comparing JEPQ to peers like QQQI and GPIQ, focusing on the trade-off between consistent monthly cash flow and total return potential in a volatile tech market.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is experiencing significant market interest following a landmark agreement with the U.S. administration to invest heavily in domestic manufacturing and offer discounted pricing in exchange for a three-year tariff exemption. Investors are actively discussing the implications of this major policy deal on the company's long-term profitability and its upcoming shift to a NYSE listing as the firm continues to prioritize its oncology pipeline and strategic growth initiatives.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is currently trending as markets react to renewed speculation of a diplomatic framework regarding tensions in the Strait of Hormuz. While some investors are positioning for a potential relief rally, significant community debate persists regarding the credibility of these reports, with many participants remaining cautious of recurring market volatility and conflicting geopolitical signals.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is facing significant selling pressure after reporting full-year guidance that pushed expectations for demand recovery into late 2027. Investors are actively debating the company's turnaround progress and leadership credibility, with many highlighting concerns over debt levels and the stock's long-term underperformance compared to sector peers.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending as investors weigh potential institutional rebalancing and short interest against the company's role in the growing drone and defense technology sector. The community is actively debating the impact of upcoming earnings, the company's commercial scaling progress, and whether the recent volatility presents a buying opportunity or a deeper fundamental reset.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BRCHF $AAPL has been behind in the ai race but due to the number of people with iphones and other devices what if they incorporated the akida which would distinguish them in a big way away from the cloud?

Marc Trageser

2paccs

Zak Ken

Andy Fenoglio

StockTwits For Android 

Brainchip Holdings Ltd

Apple Inc

 has been behind in the ai race but due to the number of people with iphones and other devices what if they incorporated the akida which would distinguish them in a big way away from the cloud?